000 08579cam a2200865Mi 4500
001 on1103254252
003 OCoLC
005 20220712091110.0
006 m d
007 cr |n|||||||||
008 140307t20152015paua ob 001 0 eng d
010 _a 2014009474
040 _aVT2
_beng
_cVT2
_dOCLCO
_dYDXCP
_dNLE
_dOCLCF
_dYDX
_dN$T
_dIAV
_dD6H
_dAGLDB
_dIGB
_dCN8ML
_dSNK
_dINTCL
_dMHW
_dBTN
_dAUW
_dVTS
_dAU@
_dUWO
_dG3B
_dS8I
_dS8J
_dS9I
_dSTF
_dSCB
_dCOCUF
_dUAB
_dCEF
_dK6U
_dUSU
_dOCLCO
_dOCLCA
_dOCLCO
019 _a921983596
_a1104427773
_a1104441122
_a1104449479
_a1107546129
_a1109954492
020 _a9781451186857
_q(alk. paper)
020 _a1451186851
_q(alk. paper)
020 _a9781496324436
_q(electronic bk.)
020 _a1496324439
_q(electronic bk.)
020 _a9781469883496
_q(electronic bk.)
020 _a146988349X
_q(electronic bk.)
029 1 _aAU@
_b000062429624
035 _a(OCoLC)1103254252
_z(OCoLC)921983596
_z(OCoLC)1104427773
_z(OCoLC)1104441122
_z(OCoLC)1104449479
_z(OCoLC)1107546129
_z(OCoLC)1109954492
050 4 _aRC270.3.R35
060 1 0 _aQZ 241
072 7 _aHEA
_x039000
_2bisacsh
072 7 _aMED
_x014000
_2bisacsh
072 7 _aMED
_x022000
_2bisacsh
072 7 _aMED
_x112000
_2bisacsh
072 7 _aMED
_x045000
_2bisacsh
082 0 0 _a616.99/407575
_223
049 _aMAIN
130 0 _aNuclear oncology (Aktolun)
_91233319
245 1 0 _aNuclear oncology /
_c[edited by] Cumali Aktolun, MD, MSc, Visiting Professor, Department of Radiology, Molecular Imaging Program at Stanford, School of Medicine, Standford University, Palo Alto, California, Stanley J. Goldsmith, MD, Professor, Department of Radiology and Medicine, Sanford and Joan Weill College of Medicine at Cornell University, Director-Emeritus, Division of Nuclear Medicine and Molecular Imaging, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York .
264 1 _aPhiladelphia :
_bWolters Kluwer,
_c[2015]
264 4 _c©2015
300 _a1 online resource (xxii, 711 pages :)
_billustrations (some color)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _adata file
_2rda
380 _aAktolun
504 _aIncludes bibliographical references and index.
505 0 0 _tBrain tumors /
_rZuzan Cayci --
_tHead and neck carcinomas /
_rMuhammad Ali Chaudhry, Lujaien Al-Rubaiey Kadhim, and Richard L. Wahl --
_tThyroid carcinoma /
_rCumali Aktolun, Umut Elboga and Muammer Urhan --
_tParathyroid tumors /
_rChristopher J. Palestro and Kenneth J. Nichols --
_tEsophageal carcinoma /
_rMark Dunphy and Heiko Schoder --
_tGastric carcinoma-I /
_rKen Herrmann [and others] --
_tGastric carcinoma-II /
_rKemal Metin Kir and Elgin Ozkan --
_tPancreatic carcinoma /
_rChristina Blumel and Andreas K. Buck --
_tColorectal carcinoma /
_rGregory C. Ravizzini, Revathy B. Lyer, and Homer A. Macapinlac --
_tLiver tumors /
_rScarlett Lewitschnig [and others] --
_tBreast carcinoma /
_rCumali Aktolun, Muammer Urhan, and Umut Elboga --
_tPulmonary carcinoma /
_rPietro Muto [and others] --
_tRenal carcinoma /
_rAntonija Balenovic, Jasna Mihailovic, and Katherine Zukotynski --
_tProstate carcinoma /
_rMarina Hodolic and Stanley J. Goldsmith --
_tUterine and cervical carcinoma /
_rBerna Degirmenci Polack --
_tOvarian carcinoma /
_rMarie Lacombe [and others] --
_tTesticular germ cell tumors /
_rChristoph Oing, Carsten Bokemeyer, and Karin Oechsle --
_tTumors of the adrenal glands /
_rShinji Yamamoto, Per Hellman and Anders Sundin --
_tNeuroendocrine tumors /
_rLisa Bodei [and others] --
_tLymphoma and leukemia /
_rJasna Mihailovic and Stanley J. Goldsmith --
_tMelanoma /
_rAlice Lorenzoni [and others] --
_tNeuroblastoma /
_rEttore Seregni [and others] --
_tBone tumors /
_rJohannes Czernin and Ken Herrmann --
_tPediatric tumors /
_rReza Vali and Martin Charron --
_tCancer of unknown primary /
_rZohar Keidar, Gad Abikhzer, and Ron Epelbaum --
_tAssessment of lymph nodes in oncology /
_rAnsje S. Fortuin [and others] --
_tSentinel lymph node detection and imaging in oncology /
_rGang Cheng, Drew A. Torigian and Abass Alavi --
_tPET/CT hybrid imaging in radiotherapy planning /
_rEgesta Lopci [and others] --
_tBone mineral densitometry in oncology /
_rWilliam D. Leslie --
_tNon-FDG PET/CT imaging in oncology /
_rCristina Nanni [and others] --
_tAssessment of response to antitumor treatment /
_rMasahiro Yanagawa [and others] --
_tRadionuclide imaging for the assessment of toxicity due to chemotherapy /
_rMarcel P.M. Stokkel and Linda de Wit-van der Veen --
_tRadionuclide imaging of multidrug resistance /
_rSabina Dizdarevic and A. Michael Peters. --
_tRadionuclide imaging of tumor hypoxia and its clinical implications /
_rGang Niu and Xiaoyuan Chen --
_tRadionuclide imaging of tumor cell apoptosis /
_rPaola A. Erbe [and others] --
_tRadionuclide imaging of tumor angiogenesis /
_rZhao-Hui Jin, Takako Furukawa, and Tsuneo Saga --
_tRadionuclide imaging of tumor cell proliferation /
_rSridhar Nimmagadda and Anthony F. Shields --
_tRadionuclide imaging of human epidermal receptors /
_rSibaprasad Bhattacharyya [and others] --
_tRadionuclide imaging of integrins /
_rMasashi Ueda, Takashi Temma, and Hideo Saji --
_tRadionuclide imaging of annexins /
_rChristel Vangestel [and others] --
_tRadiochemistry in nuclear oncology /
_rRoland Haubner and Olaf Prante --
_tAdvances in nuclear and optical imaging of tumors : multi-modality, small-animal, and intraoperative technologies /
_rPat Zanzonico.
520 8 _aNuclear Oncology a contemporary narrative of the role of nuclear medicine in oncology with an emphasis on SPECT/CT and PET/CT with additional comments when appropriate on the potential application of PET/MR and to a lesser degree, targeted radionuclide therapy. This book focuses on the use of radionuclides in the diagnosis and treatment of malignant diseases. It describes relevant approved and investigational clinical applications, instrumentation and technology, chemistry and practical clinical issues in nuclear oncology. The basic science and current research topics of nuclear oncology are addressed in separate chapters. Nuclear medicine has become an essential component to all phases of the management of the patient with a malignant tumor and in some cases, even benign neoplasms. The standard of practice for many tumors requires PET/CT imaging at various stages of diagnosis and management. In addition to clinical applications, ongoing investigational efforts, which more and more involve multi-institutional protocols, are also presented.Features:;*;Focuses on the use of radionuclides in the diagnosis and treatment of malignant diseases;*;Emphasizes SPECT/CT and PET/CT with additional emphasis on the potential application of PET/MR;*;Describes relevant approved and investigational clinical applications, instrumentation and technology, chemistry and practical clinical issues in nuclear oncology.
590 _aeBooks on EBSCOhost
_bEBSCO eBook Subscription Academic Collection - Worldwide
650 0 _aCancer
_xRadionuclide imaging.
_91233320
650 0 _aCancer
_xRadiotherapy.
_9318288
650 0 _aRadioisotope scanning.
_9134341
650 1 2 _aRadionuclide Imaging
_91048397
650 1 2 _aNeoplasms
_xdiagnostic imaging
_91233321
650 2 2 _aNeoplasms
_xradiotherapy
_9880453
650 2 2 _aRadionuclide Imaging
_xmethods
_91178060
650 2 2 _aRadiotherapy
_xmethods
_9952845
650 2 _aRadiation Oncology
_9882909
650 6 _aCancer
_xScintigraphie.
_91233322
650 6 _aCancer
_xRadiothérapie.
_9882911
650 6 _aScintigraphie.
_91048399
650 7 _aHEALTH & FITNESS
_xDiseases
_xGeneral.
_2bisacsh
_988045
650 7 _aMEDICAL
_xClinical Medicine.
_2bisacsh
_991637
650 7 _aMEDICAL
_xDiseases.
_2bisacsh
_988037
650 7 _aMEDICAL
_xEvidence-Based Medicine.
_2bisacsh
_991638
650 7 _aMEDICAL
_xInternal Medicine.
_2bisacsh
_991639
650 7 _aCancer
_xRadionuclide imaging.
_2fast
_0(OCoLC)fst00845472
_91233320
650 7 _aCancer
_xRadiotherapy.
_2fast
_0(OCoLC)fst00845473
_9318288
655 4 _aElectronic books.
700 1 _aAktolun, C.
_q(Cumali),
_d1961-
_eeditor.
_91233323
700 1 _aGoldsmith, Stanley J.,
_eeditor.
_91233324
776 0 8 _iPrint version:
_z9781451186857
_z1451186851
_w(DLC) 2014009474
_w(OCoLC)872635336
856 4 0 _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1484404
887 _aRC270.3.R35N83 2015
938 _aEBSCOhost
_bEBSC
_n1484404
938 _aYBP Library Services
_bYANK
_n12399327
938 _aYBP Library Services
_bYANK
_n13669001
994 _a92
_bINOPJ
999 _c2839340
_d2839340